Home - Products - Others - Other Targets - 4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine

4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine

CAS No. 22276-99-9

4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine ( 5-bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine; )

Catalog No. M29555 CAS No. 22276-99-9

4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine is a marine derived natural products found in Echinodictyum sp.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine is a marine derived natural products found in Echinodictyum sp.
  • Description
    4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine is a marine derived natural products found in Echinodictyum sp.
  • Synonyms
    5-bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine;
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22276-99-9
  • Formula Weight
    213.0
  • Molecular Formula
    C6H5BrN4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    BrC1=CNC=2N=CN=C(N)C12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Taxifolin

    (+)-Taxifolin,Flavonoid, antioxidant. Inhibits lipogenesis in cancer cells, most likely by targeting fatty acid synthase activity.

  • 8-Geranyloxy-5,7-dim...

    8-Geranyloxy-5,7-dimethoxycoumarin is a natural product of Toddalia, Rutaceae. The catalog number is TN3277 and the CAS number is 1228175-65-2. 8-Geranyloxy-5,7-dimethoxycoumarin can be used as a reference standard.

  • S961

    S961 is an high-affinity and selective insulin receptor (IR) antagonist with IC50s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.